Back
EyePoint Pharmaceuticals Stock Price Chart
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32
EYPT
EyePoint Pharmaceuticals
Last Price:
$6.25
Seasonality Move:
16.96%
7 Day Trial
ALL ACCESS PASS
$
7
Apple just traded your privacy for $20 Billion
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight buying pressure.
EyePoint Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.51 | Sell |
| 20-day SMA: | 6.45 | Sell |
| 50-day SMA: | 7 | Sell |
| 200-day SMA: | 8.51 | Sell |
| 8-day EMA: | 6.4 | Sell |
| 20-day EMA: | 6.54 | Sell |
| 50-day EMA: | 6.97 | Sell |
| 200-day EMA: | 9.15 | Sell |
EyePoint Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 43.36 | Sell |
| Chaikin Money Flow: | 342001 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6 - 6.88) | Sell |
| Bollinger Bands (100): | (6.39 - 9.79) | Sell |
EyePoint Pharmaceuticals Technical Analysis
| Mar 10 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 10 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for EyePoint Pharmaceuticals Stock
Is EyePoint Pharmaceuticals Stock a Buy?
-
EyePoint Pharmaceuticals share price is 6.23 while EYPT 8-day simple moving average is 6.51, which is a Sell signal.
-
The stock price of EYPT is 6.23 while EyePoint Pharmaceuticals 20-day SMA is 6.45, which makes it a Sell.
-
EyePoint Pharmaceuticals 50-day simple moving average is 7.00 while EYPT share price is 6.23, making it a Sell technically.
-
EYPT stock price is 6.23 and EyePoint Pharmaceuticals 200-day simple moving average is 8.51, creating a Sell signal.
EYPT Technical Analysis vs Fundamental Analysis
Sell
32
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy or a Sell?
-
EyePoint Pharmaceuticals stock is rated a SellThe current EyePoint Pharmaceuticals [EYPT] share price is $6.23. The Score for EYPT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
EyePoint Pharmaceuticals Stock Info
Market Cap:
428.2M
Price in USD:
6.23
Share Volume:
1.1M
EyePoint Pharmaceuticals 52-Week Range
52-Week High:
23.65
52-Week Low:
5.54
Sell
32
EyePoint Pharmaceuticals (EYPT)
is a Sell
EyePoint Pharmaceuticals Share Price Forecast
-
What is the EyePoint Pharmaceuticals stock price today?The EyePoint Pharmaceuticals stock price is 6.23 USD today.
-
Will EYPT stock go up or go down?EyePoint Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is EyePoint Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, EyePoint Pharmaceuticals is overvalued.
Is EyePoint Pharmaceuticals Stock a Buy?
-
EyePoint Pharmaceuticals share price is 6.23 while EYPT 8-day exponential moving average is 6.40, which is a Sell signal.
-
The stock price of EYPT is 6.23 while EyePoint Pharmaceuticals 20-day EMA is 6.54, which makes it a Sell.
-
EyePoint Pharmaceuticals 50-day exponential moving average is 6.97 while EYPT share price is 6.23, making it a Sell technically.
-
EYPT stock price is 6.23 and EyePoint Pharmaceuticals 200-day simple moving average is 9.15, creating a Sell signal.
Fundamental Analysis of EyePoint Pharmaceuticals
Is EyePoint Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.10 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.
Technical Analysis of EyePoint Pharmaceuticals
Should I short EyePoint Pharmaceuticals stock?
-
EYPT Moving Average Covergence Divergence (MACD) indicator is -0.15, suggesting EyePoint Pharmaceuticals is a Sell
-
EyePoint Pharmaceuticals Relative Strength Index (RSI) is 43.36, which suggest EyePoint Pharmaceuticals is oversold
-
The Bollinger Bands (25) for EyePoint Pharmaceuticals is (6 - 6.88), which suggest EyePoint Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for EyePoint Pharmaceuticals is (6.39 - 9.79), which suggest EyePoint Pharmaceuticals is a Sell
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.